Background. We have previously shown that the rat kidney reabsorbs metabolically significant amounts of iron and that it expresses the divalent metal transporter 1, DMT1. The Belgrade (b ) rat carries a mutation in DMT1 gene, which causes hypochromic, microcytic anemia due to impaired intestinal iron absorption and transport of iron out of the transferrin cycle endosome. In the duodenum of b/b rats, expression of DMT1 mRNA and protein is increased, suggesting a feedback regulation by iron stores. The aim of this study was to investigate iron handling and DMT1 expression in the kidneys of Belgrade rats.
The Belgrade (b) rat and the equivalent murine model, mk mouse, carry a nonconservative glycine-to-arginine substitution, G185R, in the putative TM4 of the divalent metal transporter, DMT1 (also DCT1, Nramp2, Slc11-A2) [1] [2] [3] The phenotype is a microcytic anemia, which is inherited as an autosomal-recessive trait. b/b rats exhibit defective iron uptake by the gastrointestinal tract and deficient iron transport in erythroid cell precursors despite increased total iron binding capacity [4] . Bone marrow transplantation studies demonstrated that mk/mk mice have a hematopoietic defect in addition to an intestinal defect in iron metabolism [5] . In b/b rats, sideroblasts are absent from the bone marrow and serum iron is also elevated, although no iron deposits can be found in these animals [6] . In b/b rats, transport of iron out of the endosome to the cytoplasm as part of the transferrin cycle is impaired [7] . In reticulocytes, iron acquisition and hemoglobin synthesis are reduced [8, 9] . Transport alterations were also seen with the nontransferrin-bound iron [10, 11] , which suggested that the defect was not the release from transferrin, but in an iron transporter or in a protein that regulates a transporter. Subsequent studies demonstrated that the common pathway is DMT1, which provides the actual iron transfer across the plasma membrane [12] .
Functionally, the G185R mutation in DMT1 causes diminished iron transport into developing erythroid cells [1, 7, 9] . In vitro studies using HEK293 cells overexpressing wild-type and mutated DMT1 have shown that the b allele encodes a protein with little or no activity in iron uptake assays [12] . In the mouse, Northern blot analysis on duodenal samples indicates that mk/mk animals exhibit a dramatic increase in DMT1 mRNA levels compared to ϩ/mk mice [13] . This increase in mRNA expression is paralleled by a concomitant increase in DMT1 protein expression in the duodenum [13] , but not in the kidneys of these animals [14] . Immunohistochemical analysis shows that, in contrast to normal mouse enterocytes from mice kept on an iron-deprived diet, little or no DMT1 expression can be seen at the apical membrane in mk/mk mice, indicating that the G185R mutation in DMT1 affects the membrane targeting of the protein in mk/mk enterocytes and that, in an attempt to compensate for the defective protein, DMT1 is upregulated at both mRNA and protein level [13] . Interestingly, the renal expression of DMT1 is drastically decreased compared with that seen in ϩ/mk animals [14] . The authors suggested that these changes are suggestive of a feedback regulation of DMT1 expression by iron stores in the duodenum, but not in the kidney.
The phenotype of the Belgrade defect indicates that the anemia in rodents is often fatal unless more iron is made available, by either increasing dietary iron or by direct iron injections [4, 15] . However, direct iron injections cannot fully correct the defect associated with the b/b phenotype [4] , suggesting that organs other than the gastrointestinal tract are also affected by this mutation, thereby contributing to total body iron homeostasis.
Recently, we have demonstrated that a metabolically significant amount of iron is filtered at the glomerulus and the majority is reabsorbed along the nephron [16] . We have also provided molecular evidence that DMT1 mRNA and protein are expressed along nephron sites where iron reabsorption takes place [17] . The described distribution of DMT1 protein is consistent with a role for DMT1 in apical iron entry by the distal nephron while in the proximal tubule DMT1 is potentially involved in the transport of iron out of the endocytic pathway.
The aim of this study was to investigate the consequences of the lack of DMT1 protein on renal handling of iron and other electrolytes and to examine the expression of DMT1 in the kidneys of Belgrade rats. Three approaches were taken. First, a multielement analysis using inductively coupled plasma mass spectrometry was performed on urine and plasma samples collected from ϩ/b and b/b rats. Subsequently, the renal b/b phenotype was compared to that of ϩ/b kidneys by histologic examinations. Finally, intrarenal DMT1 mRNA and protein distributions were examined by Northern analysis, semiquantitative immunoblotting, and immunofluorescence microscopy. Here, we report that the G185R mutation at DMT1 produces profound structural changes and results in the lack of detectable mature DMT1 protein in the kidneys of b/b rats, and that mechanisms other than DMT1 must be responsible for iron reabsorption by the rat kidney.
METHODS

Breeding and maintenance of b/b rats
All experiments were performed within guidelines set down in the United Kingdom's Animals (Scientific Procedures) Act 1986. Anemic Belgrade ϩ/b rats were bred from stock obtained from Dr Michael Garrick (SUNY, Buffalo, NY, USA). Animals were descendants of the original Belgrade colony, which has previously been backcrossed for 10 generations onto a Harlan Sprague-Dawley Wistar background [4] . These animals were subsequently maintained as a closed colony in the Biological Sciences Unit (University of Manchester, Manchester, UK) by breeding homozygous b/b males to heterozygous ϩ/b females. The progeny were visually discriminated given the paler appearance and the reduced size of b/b vs. ϩ/b rats.
Experimental animals
b/b rats inherit severe hypochromic, microcytic anemia as an autosomal-recessive trait [6] . Garrick et al [4] have shown dietary iron supplementation to improve husbandry without altering the underlying defect. Preliminary experiments showed that feeding ϩ/b rats the ironsupplemented diet described by Garrick et al [4] does not produce histologic or molecular alterations (assessed by hematoxylin-eosin staining and Western blotting, respectively) compared to ϩ/b rats fed a normal iron-containing diet (not shown). We have also observed no morphologic changes in kidney structure in normal rats maintained on this diet and in ϩ/b control rats fed the iron-supplemented diet. Altogether our preliminary observations strongly suggested that the b/b renal phenotype is due to the b/b genotype rather than to the small increase in dietary iron. Hence, to ensure that our observations were due to the DMT1 mutation rather than to the associated anemia, age-matched (days) male ϩ/b (184.5 Ϯ 8.3; N ϭ 4) and b/b (136.0 Ϯ 3.0; N ϭ 4) rats were maintained for 3 weeks on an iron-supplemented diet produced by Special Diet Services (Whitman, Essex, UK) and were given deionized water ad libitum. After this period, animals were individually housed in Home Office-approved metabolism cages for 8 days. For the first 5 days of the experiment (an acclimatization period), food and water were changed daily but no data collection was made. The experimental period was started on day 6 and continued through days 7 and 8 of the experiment. Body weight and food and water intake were measured. There were also 24-hour collections of feces and urine. Data for days 6 to 8 were averaged to give a 24-hour intake or output value for each animal. Samples were stored in polypropylene vials and kept at Ϫ20ЊC prior to analysis.
Upon completion of the experiment, anesthesia was induced with Inactin (5-ethyl-5(1 Ј -methyl-propyl)-2-thio-barbiturate) (Sigma RBI, Poole, Dorset, UK) at a dose of 100 mg · kg Ϫ1 intraperitoneally. A large terminal blood sample was extracted from the descending aorta of the animal using a 21 G needle attached to a short length of portex polypropylene catheter. We have previously noted that blood samples collected from the b/b rats were more prone to hemolysis than those collected from ϩ/b animals. To prevent this, blood samples were collected directly into heparinized vials without any application of suction. Upon completion of the collection, the left and right kidneys were removed and snap-frozen in liquid nitrogen for Northern and Western analyses, for histologic examination, and for immunofluorescence microscopy (see below). Hemolysis was detected by assaying for serum hemoglobin using a kit from Sigma (Poole, Dorset, UK).
Iron concentration in the serum, urine, feces, and food was measured using inductively coupled plasma mass spectrometry (ICP-MS) (Hewlett Packard 4500, Stockport, UK). Food and feces were acid-digested using concentrated nitric acid (HNO 3 ). Food/fecal samples were weighed and then placed into an oven at 90ЊC and desiccated. Approximately 0.2 g of desiccated sample was placed into a loosely capped vial containing 10 mL of 18 N HNO 3 and warmed to 90ЊC for 24 hours to dissolve the sample into solution. The cap was removed and the oven temperature reduced to 58ЊC to drive off the acid. Once the acid had completely evaporated, the sample was resuspended in 5 mL of 2 N HNO 3 . Samples were measured by ICP-MS using 2 N HNO 3 as a blank. Urine samples were diluted 1:5 with tetramethylammonium hydroxide (TMA-OH) and measured by ICP-MS using TMA-OH as a blank. Urine osmolality was measured on the day of the experiment using a cryoscopic osmometer (Roebling Camlab, Cambridge, UK).
Serum iron concentration was measured by flame atomic absorption spectrophotometry (FAAS) (Perkin Elmer 3100, Braknell, UK) as described previously [16] . Serum creatinine concentrations were determined using Sigma Diagnostics Creatinine kit according to the manufacturers' instructions. Urine pH was measured after collecting 250 L samples directly from the animals' bladders and values were determined using a Beckman pH meter (High Wycombe, UK). For measurements of blood pH, animal procedures were reviewed and approved by the State University of New York at Buffalo Institutional Animal Care and Use Committee. Three b/b and three ϩ/b male rats, all 9 months old, were anesthetized with halothane (Sigma-Aldrich, St. Louis, MO, USA). Blood was obtained by retro-orbital sinus puncture and was collected in heparinized microhematocrit capillary tubes. The tubes were sealed at both ends with Critoseal sealing clay and placed on ice. Blood pH was measured for duplicate samples at 37ЊC using a Radiometer ABL5 Blood Gas System (London Scientific, London, UK). Instrument performance was verified by using Bio-Rad Blood Gas Controls: level 1, acidosis, 6.80 (range 6.80 to 6.830); level 2, normal, 7.39 (range 7.38 to 7.42); and level 3, alkalosis, 7.61 (range 7.58 to 7.64) (Bio-Rad, Anaheim, CA, USA).
RNA extraction and Northern analysis
At the end of the metabolic cage studies, adult, male ϩ/b and b/b rats were killed, the kidneys removed and snap-frozen using liquid N 2 . Duodenum tissue scrapes from heterozygous or homozygous Belgrade rats were used as a positive control for transcript up-regulation [18] . Total RNA was isolated by the guanidine isothyocyanate method [19] using cesium-trifluoroacetic acid (Life Technologies, Paisley, UK) as described previously [20] . Total RNA (15 g/lane) was separated in a 1% agarose gel in the presence of 2.2 mol/L formaldehyde and transferred to Hybond-N filters (Amersham Pharmacia Biotech, Little Chalfont, UK). Filters were probed using a 32 P-labeled cDNA probe (17) containing nucleotides 85-1600 of rat DMT1 (Genbank accession number AF02-9757). After overnight hybridization at 42ЊC in a buffer containing 7% sodium dodecyl sulfate (SDS), 0.5 mol/L NaHPO 4 (pH 7.2), 1 mmol/L ethylenediaminetetraacetic acid (EDTA), 50 mmol/L bovine serum albumin (BSA), supplemented with denatured salmon sperm DNA (100 g/mL hybridization solution, Life Technologies), filters were washed twice with 5 ϫ standars sodium citrate (SSC), 0.1% SDS at 48ЊC for 15 minutes, followed by two washes in 0.1 ϫ SSC, 0.1% SDS at 60ЊC for 15 minutes [20] . Autoradiography was performed at Ϫ80ЊC using Biomax MS film (Kodak Biomax MS, Hemel Hempstead, UK). To control for equal loading of RNA, membranes were subsequently probed with a 32 P-labeled rat ␤-actin cDNA probe (Genbank accession number V01217).
Preparation of microsomal membrane fraction and Western analysis
Alternative splicing of DMT1 generates two transcripts that differ in the 3Ј-end of the molecule [2, 21] . One of these contains an iron response element (IRE) element in its 3Ј-UTR. We have previously generated, affinity-purified, and characterized an antiserum against corresponding amino acid 1-21 of rat DMT1, (Sigma Genosys, Cambridge, UK), which recognizes both IRE and NIRE (non-IRE) isoforms of the protein. Our antiserum detects peptide/protectable immunoreactive species of 60 to 90 kD in microsomal membrane fractions from rat kidney [17] .
Aliquots of microsomal membrane fraction containing 30 g of protein prepared as described elsewhere [17] were incubated for 5 minutes at room temperature and separated on an 8% SDS-polyacrylamide gel electrophoresis (PAGE). To reduce between-group variability, kid-neys were processed in groups of two, one from each experimental condition (i.e., ϩ/b and b/b). Proteins were transferred to BioTrace nitrocellulose membrane (Pall Gelman Sciences, Northampton, UK) and the membranes were incubated for 1 hour at room temperature in the affinity-purified anti-DMT1 antiserum [17] . The membranes were washed with several changes of Trisbuffered saline with 20% Tween (TBST) [17] , then incubated for 1 hour at room temperature in goat antirabbit IgG conjugated to horseradish peroxidase (Dako, Ltd., Ely, UK) diluted 1:5000 in TBST. A further washing step was followed by visualization of the signal by enhanced chemiluminescence (ECL Plus) (Amersham Pharmacia Biotech, Little Chalfont, UK) according to the manufacturer's protocol. Experiments were repeated in triplicate. Protein concentration was determined using the Bradford method (Bio-Rad Laboratories, Ltd., Hertfordshire, UK). The protein equivalency of sample loading volumes was demonstrated by staining of a SDS-PAGE gel with Coomassie blue (not shown). Membranes incubated in the absence of the primary antibody or with antiserum preabsorbed with an excess of the immunizing peptide served as negative controls.
Histology and immunofluorescence microscopy
To study DMT1 intrarenal distribution in ϩ/b and b/b rats (four to six for each group) animals were anesthetized with Inactin (Sigma RBI) at a dose of 100 to 110 mg/kg intraperitoneally. Perfusion was carried out as described elsewhere [17] and 4 m thick cryosections were cut using a Leica CM3050 cryostat (Leica Instruments GmbH, Nussloch, Germany), thaw-mounted onto Superfrost Plus slides (BDH, Poole, Dorset, UK) and kept at -20ЊC until used. For histologic examination, slides were thawed, dipped into Meyer's hemalum (BDH, Poole, Dorset, UK), dehydrated through ethanol series, and mounted using Eukitt (O Kindler GmbH & Co., Freiburg, Germany). DMT1 immunodetection was performed as previously described using RA2719 affinitypurified anti-DMT1 polyclonal antiserum [17] . Secondary antibody was goat antirabbit Alexa 594 (Molecular Probes, Inc., Eugene, OR, USA) diluted into phosphatebuffered saline (PBS) containing 5% normal goat serum and 1% BSA. Intrarenal distribution of DMT1 and aquaporin 1 (AQP1) or DMT1 and aquaporin 2 (AQP2) was assessed on serial cryostat sections from animals perfusion-fixed as described above. Both AQP1 and AQP2 antisera (rabbit antirat) were obtained from Alpha Diagnostic International, Inc. (Mile Elm, UK) After rinsing with PBS, the sections were mounted using Dako-Glycergel TM (Dako, Ltd., High Wycombe Bucks, UK) added with 2.5% 1,4-diazabicyclo-[2.2.2]octane (DABCO) (Sigma). Negative controls were carried out by preincubating the DMT1 antiserum with an excess of antigenic peptide and by omitting the primary antibodies.
Slides were viewed using a Zeiss Axioplan 2 microscope with 2.5-63ϫ objectives. Images were acquired using a Hamamatsu digital camera and processed using the software package KS300, version 3.0 (Carl Zeiss, Ltd., Welwyn Garden City, UK).
Iron deposits in rat kidney sections were visualized by russian blue staining using the Accustain Iron Stain Kit (Sigma Diagnostics, St. Louis, MO, USA) following manufacturer's instructions.
Statistical analysis
For measurements of serum, urine, and fecal iron concentration, statistical significance was assessed using single-factor analysis of variance (ANOVA). Bonferroni's multiple comparison post hoc test was used to indicate significant differences between groups. Values for ion intakes and outputs are in mol/day Ϫ1 · 100 g body weight Ϫ1 unless otherwise noted. For the semiquantitative immunoblotting, one-way ANOVA with Dunnett's post-hoc test was used to compare differences between ϩ/b and b/b rats [22] . Data are expressed as means ϩ/Ϫ SEM throughout the text, where N ϭ number of animals unless otherwise stated. Significance was accepted at P Ͻ 0.05. Statistical significance for serum creatinine concentrations of b/b and ϩ/b animals was calculated using a Student t test. For measurements of blood pH, data were analyzed on an AT-compatible computer using the program STATA (Stata Corporation, College Station, TX, USA). Both ANOVA and t test were performed, taking P Յ 0.05 to be significant.
RESULTS
Functional observations
Food and water intake and urine output. Data collected for the intake of food indicate that b/b rats ate significantly more than heterozygous ϩ/b rats (11.57 Ϯ 0.26 g/day Ϫ1 · 100 g body weight Ϫ1 vs. 9.44 Ϯ 0.36 g/day Ϫ1 · 100 g body weight Ϫ1 ; N ϭ 4; P Ͻ 0.05; ANOVA). Mean body weights of the two groups were also significantly different [200 Ϯ 4.2 g (ϩ/b) and 150 Ϯ 0
Water intakes were 11.95 Ϯ 0.629 mL/day Ϫ1 · 100 g body weight Ϫ1 and 14.77 Ϯ 0.81 mL/day Ϫ1 · 100 g body weight Ϫ1 for ϩ/b and b/b rats, respectively (N ϭ 4; NS).
Measurements of urinary outputs indicate that ϩ/b and b/b rats voided comparable amounts of urine (3.427 Ϯ 0.53 mL/day Ϫ1 · 100 g body weight Ϫ1 vs. 3.426 Ϯ 0.47 mL/day Ϫ1 · 100 g body weight Ϫ1 ; N ϭ 4; NS). Urinary osmotic outputs were 3.05 Ϯ 0.22 mOsm/day Ϫ1 · 100 g body weight Ϫ1 and 3.25 Ϯ 0.28 mOsm/day Ϫ1 · 100 g body weight Ϫ1 for ϩ/b and b/b rats, respectively (N ϭ 4; NS).
Urinary outputs of individual ions are detailed in Fig-Fig. 1. Food, serum Individual ion intake, serum levels, and fecal output. Electrolytes intake, serum levels, and fecal outputs for ϩ/b and b/b rats are presented in Table 1 . The table shows that serum K ϩ was decreased, while serum Mg 2ϩ concentration was increased in b/b compared to ϩ/b rats.
The general trend is that fecal excretion of all ions is increased in b/b compared with ϩ/b rats. This mirrors food intake, which is also increased in b/b compared with ϩ/b rats. Serum electrolyte levels do not differ between the two experimental groups. The only exception is K ϩ , whose concentration was significantly reduced in b/b compared with ϩ/b animals. With respect to iron, b/b rats showed a substantial increase in the amount of iron excreted in the feces compared to ϩ/b animals (69.11 Ϯ 8.05 mol/L · day Ϫ1 · 100 g body weight Ϫ1 vs. 52.42 Ϯ 2.01 mol/L · day Ϫ1 · 100 g body weight Ϫ1 ) (N ϭ 4; P Ͻ 0.05) (see Fig. 1 ). Serum concentrations, mmol/L/day · 100 g body weight Ϫ1 (Na ϩ , K ϩ , Ca 2ϩ , and Mg 2ϩ ); mol/L/day · 100 g body weight Ϫ1 (Zn 2ϩ , Cu 2ϩ , and Mn 2ϩ ); nmol/L/day · 100 g body weight Ϫ1 (Ni 2ϩ ); food intake and fecal output, nmol/L/day · 100 g body weight Ϫ1 (Cu 2ϩ and Ni 2ϩ ). I/S/O is intake/serum levels/output. 
Other parameters
There was no indication of proteinuria in either experimental group (N ϭ 6 for each condition). Urinary and blood pH were normal and not statistically different between ϩ/b and b/b rats [urine pH values, 6.08 Ϯ 0.054 vs. 6.2 Ϯ 0.09; plasma pH values, 7.4 Ϯ 0.031 vs. 7.34 Ϯ 0.004, ϩ/b vs. b/b, respectively, N ϭ 6, NS by both t test and ANOVA). Plasma creatinine values were also not statistically different between ϩ/b and b/b rats (102.52 Ϯ 3.61 mol/L Ϫ1 vs. 98.47 Ϯ 11.51 mol/L Ϫ1 , respectively, N ϭ 4, NS).
Histologic observations
Hematoxylin-eosin and iron deposits staining. Low magnification micrographs of hematoxylin-eosin staining of paraformaldehyde-fixed cryosections exhibited marked structural changes in the kidneys of b/b rats ( Fig. 3 B and D) compared to those from ϩ/b animals ( Fig. 3 A and C). These were of various degrees and consisted of an enhanced granularity of the tubular epithelium in the kidney cortex, and in an ill-defined corticomedullary junction, with projections of the medullary collecting epithelium and of the stromal component into the cortex of b/b rats (Fig. 3B) . Dilated channels were also visible just above the corticomedullary junction in the kidneys of b/b animals. Due to the lack of lining tubular epithelium, erythrocytes, and lymphocytes, these are likely to be of lymphatic nature. At higher magnification, b/b rats exhibit enhanced granularity in the tubular epithelium. In one out of four rats this hypergranularity resulted in an almost complete occlusion of the lumina of the tubules (not shown). Glomeruli of b/b rats showed increased cellularity without fibrosis or sclerosis (Fig. 3D ) or irregularity in the capillary loops. These changes were not observed in kidneys from ϩ/b rats (Fig. 3C) , although occasionally dilated spaces were still present in some, but not all, the kidneys from ϩ/b animals (not shown).
No iron deposits were found in the kidneys of ϩ/b and b/b rats due to the dietary iron supplementation over the term of the experiment (not shown).
Molecular observations
Expression of DMT1 mRNA in b/b rats. We have previously shown that high stringency Northern analysis using rat kidney mRNA probed with a probe common to both IRE and NIRE isoforms of DMT1 detected transcripts of 4.4, 4.0, and 2.4 kb [17] . Current experiments on equally loaded, ␤-actin-positive total RNA samples from ϩ/b and b/b rat kidneys indicate low expression levels of identical transcript sizes in all samples, and that the overall DMT1 mRNA expression is unchanged in the kidneys of ϩ/b and b/b animals ( Fig. 4,  left panel) . In contrast, as previously reported for the G185R mutation in rat [18] , DMT1 mRNA is up-regulated in the proximal duodenum of b/b rats (Fig. 4, right  panel) . The same figure also shows that, in agreement A total of 30 g crude membrane extracts of whole kidneys were separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) on an 8% polyacrylamide gel, blotted onto nitrocellulose membrane, and hybridized with a rabbit amino-terminus antibody against rat DMT1 sequence. The antibody was raised in rabbit against a peptide sequence (amino acid 1-21) of the putative rat DMT1, which is identical in both iron response element (IRE) and non-IRE (NIRE) isoforms, and was affinity purified as described elsewhere prior to use [14] . DMT1 immunoreactivity of crude membrane extracts from whole kidneys from ϩ/b and b/b rats (representative of four for each group). The DMT1 antiserum recognizes a doublet of approximately 61 to 63 kD in kidney extracts from ϩ/b animals, which is strongly reduced in kidney extracts from b/b animals. Equal loading onto the gel was confirmed by Coomassie staining. Molecular mass markers (kD) are shown on the left of each panel. IRE is iron response element. with previous studies [18] , DMT1-related transcripts are unchanged in the duodenum of ϩ/b animals.
Expression of DMT1 protein in b/b rats. To test the effect of the G185R mutation on rat renal DMT1 protein expression, we employed semiquantitative immunoblotting with an anti-DMT1-affinity-purified polyclonal antibody [17] and compared the DMT1 content in kidneys from ϩ/b and b/b rats. By this method, we determined that the whole kidney content of DMT1 is significantly reduced from 39.0 Ϯ 7.8 (OD/mm 2 , arbitrary units) in the ϩ/b rats to 10.02 Ϯ 2.9 (N ϭ 4, P Ͻ 0.05) (Fig. 5) . No signal was detected in rat kidney membranes from both ϩ/b and b/b animals when the anti-DMT1 antibody was preabsorbed by the antigenic peptide (not shown).
Low magnification images of immunofluorescence microscopy on rat kidney cryosections from ϩ/b and b/b rats showed a markedly reduced expression in DMT1 staining throughout the kidneys of the b/b rat (Fig. 6B ) compared to ϩ/b rats (Fig. 6A) . At higher magnification, the reduction in DMT1 immunostaining in b/b rats seems to be due to a decrease in both the intensity of the immunoreactivity and in the number of cells expressing the transporter (Fig. 7) . Figures 7A and B show that the reduction did not appear to be region-specific, as it could also be observed in proximal tubule, collecting duct and distal convoluted tubule cells (arrow and arrowheads, respectively). Occasionally, residual staining was detected intracellularly in S3 segments of the proximal tubules (Fig. 7D ). Serial sections from ϩ/b (Fig. 8A and  B) and b/b rats ( Fig. 8C and D) show that expression of AQP1, a marker for proximal tubule, is comparable between the two experimental groups (Fig. 8B and D) , indicating that the reduction of DMT1 immunofluorescence in b/b rats (Fig. 8C ) compared to ϩ/b (Fig. 8A) is not a result of alterations in proximal tubule morphology. Although not shown, similar results were obtained when serial sections from ϩ/b and b/b rats were immunostained for DMT1 and AQP2, a marker for collecting ducts. Identical results were observed using different types of fluorophores and fixation protocols (i.e., PLP fixative, not shown) and no signal was detected in slides in which the primary antibody was preabsorbed with the antigenic peptide and in slides in which the primary antibody was omitted (not shown). 
DISCUSSION
Belgrade rats have severe anemia, which negatively affects body weight, survival to adulthood, hematologic parameters and reproduction [4] . The lack of tissue iron and the elevated total iron binding capacity in b/b animals indicates that the body "iron stat" detects an iron deficiency even though serum iron levels are elevated. In the duodenum of b/b rats [18] and in that of the murine model, the mk/mk mice [13] , there is a dramatic up-regulation in the expression of the mutant DMT1 mRNA and protein, respectively, in response to iron deficiency, most likely mediated by a feedback regulatory mechanism sensing the levels of body iron in the stores. In contrast, DMT1 expression in the kidneys of mk/mk mice is strongly reduced [14] , indicating differential regulation of the transporter at the two sites. The purpose of this study was to examine the consequences of loss of functional DMT1 protein on ion handling, on morphologic changes, and on the expression levels of DMT1 in the kidneys of b/b rats. First, to test for the consequences of the defective allele in the ϩ/b vs. b/b phenotype, we assessed urinary and serum levels of different electrolytes in ϩ/b and b/b animals. Garrick et al [4] have shown that dietary iron supplements improve red blood cell count with little effect on the quality of the microcytic, hypochromic cells leaving the apparent underlying defect unaffected. To ensure that any changes seen were due to an effect of the G185R mutation rather than to the underlying anemia, all our observations were made on animals kept on an iron-supplemented diet.
We observed that serum iron levels were significantly elevated in Belgrade rats, consistent with previous observations by Garrick et al [4] and Sladic-Simic [6] . This is due to the diminished ability of the tissue to utilize iron [4] ; this inability in turn is due to the failure of iron to leave the endosomal compartment [2, 10] . Despite the increased serum iron levels, urinary excretion of iron was comparable between ϩ/b and b/b rats. Thus, if we assume that b/b rats filter more iron given the increased serum iron levels, then we must conclude that b/b rats reabsorb more iron. Given that b/b rats show iron deficiency in many tissues due to the G185R mutation in DMT1, this would be consistent with a stimulation of iron transport, through the stores (and possibly through the erythroid) regulator (see [23] for review).
Food intake was significantly increased in b/b rats, possibly as a consequence of the necessity to increase dietary iron intake. Fecal excretion of iron was also enhanced in b/b vs. ϩ/b animals. Since the ratio between fecal output and food intake is ϳ58% for b/b animals and ϳ51% for ϩ/b rats, we believe that the increased fecal iron output in b/b rats could be due to both a reduced intestinal iron absorption, as documented by Oates et al [18] , and/or to a direct consequence of the increased dietary iron intake.
Urine volume and osmolar output were not significantly different in ϩ/b and b/b animals and, with the exception of Ca 2ϩ , urine outputs of ions were also comparable between the two experimental groups. Given that DMT1 is not known to transport calcium or magnesium [21] , this dramatic increase in urinary calcium excretion result is somewhat surprising. Interestingly, urinary Mg 2ϩ excretion levels were not significantly different between the two experimental groups. Since calcium and magnesium reabsorption by the kidney proceed in parallel and can only be discriminated at the level of the distal convoluted tubule, and since in these experiments the hypercalciuria is not accompanied by hypermagnesiuria, our observations indicate that b/b rats could have a distal tubular defect. Clearly, the effects of the G185R mutation on the expression of proteins involved in the transcellular transport of calcium [Ca-adenosine triphosphatase (ATPase), Na/Ca exchanger, calbindins, calcium-sensing receptor, calcium transporters, and thiazide-sensitive Na-Cl cotransporter) and regulating paracellular magnesium permeability (paracellins) has to be evaluated.
Histologic characterization of the b/b phenotype indicates an enhanced hypergranularity in the tubular epithelium and increased cellularity compared to ϩ/b rats. In the reticulocytes of Belgrade rats, iron movement from the endosome to the mitochondria is severely impaired [2, 7, 24] . Thus, the lack of DMT1 in the intracellular compartments of proximal tubular cells could also affect intracellular organelles' function. It will be interesting to compare functional and ultrastructural features of the endosomal/mitochondrial compartments of the kidneys of b/b rats. Whatever the nature of the damage, it does not affect the expression of protein markers for the proximal tubule and collecting duct, AQP1 and AQP2, respectively (see below).
Northern analysis using total RNA samples extracted from both renal and duodenal tissue from ϩ/b and b/b rats probed with a DMT1 probe shows comparable DMT1 mRNA abundance in the kidneys of ϩ/b and b/b animals while there is considerable variation in DMT1 transcripts in the duodenum of ϩ/b and b/b rats. In contrast, we observed a consistent and reproducible upregulation in DMT1 mRNA in duodenal samples from the same animals under the same experimental conditions. This is in agreement with previous findings in the rat duodenum [18] , where DMT1 mRNA levels are enhanced in b/b but not in ϩ/b rats, and indicates that the differences between DMT1 mRNA distribution in kidney versus duodenum are due to different regulation in the two different tissues and not due to different experimental conditions. Analysis of renal protein distribution and expression indicate the almost complete lack of DMT1 protein in the G185R mutant compared to ϩ/b. This is in line with observations made by Canonne-Hergaux and Gros [14] , who have estimated a 6-to 50-fold decrease in DMT1 immunoreactivity in kidney membranes from mk/mk mice [14] . These results suggest that the mutation causes either defective posttranslational processing of the protein, leading to an absence of cell surface and endosomal expression, or to accelerated protein degradation. If one of these hypotheses is true, this indicates that in the kidney the genetic abnormality affects the stability and/or maturation of the mutant protein, which would lead to the virtual absence of the normal carrier. In vitro studies performed using transient expression of the G185R mutant in HEK293 cells [12] show that both the wild-type and mutated DMT1 protein have similar cellular localization (i.e., to the transferrin-positive recycling endosomes), and that G185R mutation is functionally deleterious. Iron accumulation in transfected cells is severely reduced (35-fold). The mutation results in decreased DMT1 expression on the cell surface. Biotinylation experiments demonstrate that both wild-type and G185R are at the plasma membrane but G185R is 4-to 10-fold less (i.e., decreased levels of mutant protein appear to contribute, but cannot fully explain the loss of function) [12] . In the duodenum of b/b rats, the absorptive defect lies in the uptake phase of transport across the microvillous membrane, it is not due to an abnormality of an iron-reductive mechanism [25, 26] while the G185R mutant appears to interfere with proper targeting to the brush border of the duodenal epithelium in vivo. The loss of function of DMT1 is caused by a combination of increased degradation and defective iron transport by the residual protein rather than by diminished transcription because the amount and site of DMT1 mRNA expression were similar in b/b rats fed a normal diet and iron-deficient Wistar rats [8] . In the duodenum of mk/mk mice, loss of DMT1 function is accompanied by an increase in the expression of the defective mRNA and protein species [13] . Similarly to the rat duodenum, in the mouse, the G185R mutation also affects the membrane targeting of the protein in mk/mk enterocytes [27] and kidney cells [14] , indicating that the effects of the G185R mutation is tissue-specific. What could be the explanation for this discrepancy? In duodenal crypt cells of b/b rats and mk/mk mice, the level of intracellular iron decreases, reflecting the change in body iron status. As a consequence, gastrointestinal iron uptake is increased, most likely by a feedback regulatory mechanism sensing the levels of body iron in the stores [18] . Canonne-Hergaux et al [13] have speculated that this could induce an increased DMT1 mRNA stability and translation rate through binding of iron-response proteins (IRPs) to the IREs located in the 3Ј UTR of isoform 1 of DMT1. The hypothesis of an alternative expression of IRPs in the kidney and the duodenum needs to be tested. The G185R mutation in DMT1 in the kidney is reminiscent of the mutation in the gene for natural resistance to intracellular infection (Nramp1), which is molecularly similar to DMT1. The G169D mutation in Nramp1 corresponds to the glycine residue immediately adjacent to the G185R mutation in DMT1 and impairs mouse resistance to infection with intracellular parasites. In both circumstances the mutations affect normal processing of the protein, with possible targeting for degradation [28] .
CONCLUSION
Our study has demonstrated that the G185R mutant results in the absence of mature DMT1 protein in the kidneys of b/b rats. Whatever the mechanism, it is clear that, despite the almost complete lack of DMT1 protein in b/b rats, these animals excrete iron at the same rate as ϩ/b animals. Since the rat kidney reabsorbs Ͼ90% of the filtered iron [16] , our results indicate that DMT1 does not appear to play a crucial role in iron reabsorption by the kidney. However, the significant hypercalciuria without hypermagnesiuria in b/b rats suggests distal tubular impairment. This is consistent with our previous functional and localization studies, which indicated that in the rat kidney DMT1 is expressed and functional at the luminal membrane in the distal nephron [16, 17] . Since proximal tubular iron transport occurs through a mechanism, which differs from DMT1 and reabsorption of iron by the distal nephron only accounts for 6% of the total iron reabsorption [abstract; Wareing et al, J Am Soc Nephrol 12:43A, 2001), an additional, unidentified mechanism must be responsible for most of the iron reabsorption by the proximal tubule. Moreover, we cannot rule out the possible role of other proteins involved in the regulation of renal iron reabsorption in the b/b rats, such as ferrireductase and/or ferroportin (i.e., Ireg1, MTP, Slc11A3) [29] [30] [31] [32] on the basolateral membrane that could be rate-limiting in iron acquisition.
